IGC Pharma Inc (IGC)
0.52
-0.02
(-3.65%)
USD |
NYAM |
May 09, 16:00
0.5195
0.00 (0.00%)
After-Hours: 20:00
IGC Pharma Market Cap: 33.11M for May 9, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 08, 2024 | 34.40M |
| May 07, 2024 | 32.23M |
| May 06, 2024 | 32.56M |
| May 03, 2024 | 32.58M |
| May 02, 2024 | 33.14M |
| May 01, 2024 | 32.38M |
| April 30, 2024 | 34.54M |
| April 29, 2024 | 29.52M |
| April 26, 2024 | 29.19M |
| April 25, 2024 | 27.41M |
| April 24, 2024 | 27.98M |
| April 23, 2024 | 29.10M |
| April 22, 2024 | 28.37M |
| April 19, 2024 | 31.23M |
| April 18, 2024 | 30.34M |
| April 17, 2024 | 37.38M |
| April 16, 2024 | 30.97M |
| April 15, 2024 | 27.99M |
| April 12, 2024 | 28.05M |
| April 11, 2024 | 33.78M |
| April 10, 2024 | 33.84M |
| April 09, 2024 | 36.65M |
| April 08, 2024 | 39.52M |
| April 05, 2024 | 41.40M |
| April 04, 2024 | 43.97M |
| Date | Value |
|---|---|
| April 03, 2024 | 40.82M |
| April 02, 2024 | 34.13M |
| April 01, 2024 | 30.34M |
| March 28, 2024 | 25.49M |
| March 27, 2024 | 25.91M |
| March 26, 2024 | 25.43M |
| March 25, 2024 | 25.49M |
| March 22, 2024 | 23.96M |
| March 21, 2024 | 21.67M |
| March 20, 2024 | 21.96M |
| March 19, 2024 | 24.10M |
| March 18, 2024 | 21.61M |
| March 15, 2024 | 20.68M |
| March 14, 2024 | 21.44M |
| March 13, 2024 | 21.22M |
| March 12, 2024 | 20.72M |
| March 11, 2024 | 21.19M |
| March 08, 2024 | 21.23M |
| March 07, 2024 | 21.03M |
| March 06, 2024 | 20.93M |
| March 05, 2024 | 21.37M |
| March 04, 2024 | 22.24M |
| March 01, 2024 | 22.31M |
| February 29, 2024 | 21.96M |
| February 28, 2024 | 22.24M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
11.86M
Minimum
Mar 18 2020
140.64M
Maximum
Feb 10 2021
39.93M
Average
29.61M
Median
Sep 08 2022
Market Cap Benchmarks
| CEL-SCI Corp | 80.97M |
| AIM ImmunoTech Inc | 21.06M |
| NovaBay Pharmaceuticals Inc | 2.600M |
| Protalix BioTherapeutics Inc | 89.85M |
| Palatin Technologies Inc | 37.76M |
Market Cap Related Metrics
| PS Ratio | 23.94 |
| Price to Book Value | 3.657 |
| Price | 0.52 |
| Earnings Yield | -50.05% |